Abstract:Abstract Background After initiation of therapy in Crohn's disease (CD), it remains unclear what the optimal endoscopic healing (EH) threshold to target is using the SES-CD and the MM-SES-CD (Modified Multiplier Simple Endoscopic Score for Crohn’s disease). We assessed MM-SES-CD and SES-CD thresholds that are best associated with low likelihood of long-term disease progression. Methods Week 48 endoscopy videos from patients with CD who participated in the CALM long-term extension LTE study were obtained and re-read by central readers to obtain a SES-CD and MM-SES-CD score, which was used for the derivation cohort. A real-world validation was performed with data from 99 patients that had clinical response using a mixed cohort of biologic therapies from the McMaster IBD database. The primary outcome was disease progression, defined as a new internal fistula/abscess, stricture, perianal fistula or abscess, CD-related hospitalization or surgery since the end of the CALM trial for the derivation cohort, and over the observed period of follow-up for the validation cohort. The maximum Youden index was calculated to determine the optimal MM-SES-CD and SES-CD thresholds. Receiver operating characteristic curve analyses compared threshold scores of various remission definitions on disease progression. Kaplan-Meier survival curve analyses were performed to compare the time to disease progression from the end of study endoscopy in the derivation cohort. Results In the derivation cohort, the optimal thresholds associated with a low likelihood of disease progression were MM-SES-CD <22.5 and SES-CD <4. A significantly greater proportion of patients with a MM-SES-CD ≥22.5 had disease progression as compared to patients with MM-SES-CD <22.5 [10/17 (58.8%) vs. 3/44 (6.8%), p<0.001]. Similarly, a significantly greater number of patients with a SES-CD ≥ 4 had disease progression compared to those with a SES-CD <4 [11/25 (44.0%) vs. 2/36 (5.6%), p<0.001]. Compared to other clinical or endoscopic remission definitions, obtaining a MM-SES-CD <22.5 at the end of the CALM study performed the best for predicting disease progression [AUC: 0.81 (95% CI: 0.68-0.94), p<0.001](sensitivity 76.9% (95% CI: 46.2-95.0), specificity 85.4% (95% CI: 72.2-93.9)). Compared to those with lower scores, patients with MM-SES-CD ≥ 22.5 (log-rank p<0.0001) and SES-CD ≥ 4 (log-rank p=0.0002) had a significantly greater probability of disease progression (Figure 1A/B). These findings were confirmed in the validation cohort (Figure 1C/D). Conclusion Achievement of MM-SES-CD <22.5 and SES-CD <4 was associated with low risk of CD progression and may be a suitable target for EH in clinical trials and practice. Our findings support that targeting EH may modify the natural course of CD.

The Endoscopic Prediction Model of Simple Endoscopic Score for Crohn's Disease (SES-CD) As an Effective Predictor of Intestinal Obstruction in Crohn's Disease: A Multicenter Long-Term Follow-Up Study

The predictive factors for postoperative intra-abdominal septic complications after intestinal resection in patients with Crohn's Disease

Correlation Between Endoscopic and Histological Validated Scoring Indices in Crohn's Disease.

The SES-CD Could Be a Predictor of Short- and Long-Term Mucosal Healing after Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients

A predictive model for colorectal cancer complicated with intestinal obstruction based on specific inflammation score

Analysis of White-Light Imaging-Based Features Predictive for Determination of Lesion Depths of Superficial Flat Esophageal Squamous Cell Carcinoma: a Retrospective Multicenter Study from China

Enhancing Patient Outcomes: A Novel Nomogram Prediction Model Based on Systemic Immune‐Inflammation Index for Esophageal Stricture After Endoscopic Submucosal Dissection

Evaluation of Crohn's Disease Activity: Validation of a Segmental Simple Ultrasound Score in a Multicenter Study

Prediction of technically difficult endoscopic submucosal dissection for large superficial colorectal tumors: a novel clinical score model

Endoscopic Evaluation at One Month After Ileocolic Resection for Crohn's Disease Predicts Future Postoperative Recurrence and Is Safe.

P409 Optimal endoscopic healing thresholds defined by MM-SES-CD < 22.5 and SES-CD < 4 are associated with low risk of disease progression in Crohn’s disease

Efficacy of Early Intervention on the Bowel Damage and Intestinal Surgery of Crohn’s Disease, Based on the Lémann Index

Mesenteric findings of CT enterography are well correlated with the endoscopic severity of Crohn's disease

P199 External validation of Intestinal Ultrasound score: IBUS-SAS with clinical (CDAI), biomarkers and endoscopic scoring system (SES-CD)

Patients with Crohn's Disease Undergoing Abdominal Surgery: Clinical and Prognostic Evaluation Based on a Single-Center Cohort in China

Different imaging techniques' diagnostic efficacy for Crohn's disease activity and external validation and comparison of MDCTAs, SES-CD and IBUSSAS

Development and validation of a model to determine the risk of esophageal strictures after endoscopic submucosal dissection for esophageal neoplasms

Validation and update of clinical score model to predict technical difficulty of colorectal endoscopic submucosal dissection: A multicenter prospective cohort study

Use of CESI,Simplified CDAI and CRP in Evaluating Extent of Lesion and Disease Activity in Small Bowel Crohn's Disease

P187 Validation of Disease Severity Index for Predicting Complicated Disease in Crohn’s Disease: A comparison study with Lémann Index

P249 Development and validation of a novel model to predict disease behavior progression in Crohn's disease patients with intestinal stenosis